Exero Medical develops a biodegradable wireless sensor for early detection of anastomotic leaks following GI surgery.

The system is designed to prevent complications by warning physicians of potential leaks, allowing early intervention.Anastomotic leaks are a common, life-threatening complication of GI surgeries, such as colorectal and bariatric surgeries.

Early detection before the clinical manifestation of an anastomotic leak is key to a favorable outcome, but diagnosis at this stage is difficult.

This delay in diagnosis affects both mortality rates and economic burdens.Exero Medicals system deploys a sensor that continuously monitors the condition of the anastomosis area, enabling early detection and preventive action before the patients condition deteriorates.In December 2020, the FDA granted breakthrough device designation for Exero Medicals wireless system designed for the early detection of potentially lethal anastomotic leaks following gastrointestinal surgery.